nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Emotional distress—Metformin—polycystic ovary syndrome	0.0223	0.118	CcSEcCtD
Ipratropium bromide—Nasal congestion—Metformin—polycystic ovary syndrome	0.00756	0.04	CcSEcCtD
Ipratropium bromide—Influenza—Metformin—polycystic ovary syndrome	0.00595	0.0315	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0057	0.0302	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00553	0.0292	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0052	0.0275	CcSEcCtD
Ipratropium bromide—Rhinitis—Metformin—polycystic ovary syndrome	0.00477	0.0253	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00474	0.0251	CcSEcCtD
Ipratropium bromide—Eye disorder—Metformin—polycystic ovary syndrome	0.00445	0.0235	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00442	0.0234	CcSEcCtD
Ipratropium bromide—Flushing—Metformin—polycystic ovary syndrome	0.00442	0.0234	CcSEcCtD
Ipratropium bromide—CYP3A4—urine—polycystic ovary syndrome	0.00435	0.113	CbGeAlD
Ipratropium bromide—Immune system disorder—Metformin—polycystic ovary syndrome	0.0043	0.0227	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00429	0.0227	CcSEcCtD
Ipratropium bromide—CYP2D6—urine—polycystic ovary syndrome	0.00428	0.111	CbGeAlD
Ipratropium bromide—Flatulence—Metformin—polycystic ovary syndrome	0.00409	0.0216	CcSEcCtD
Ipratropium bromide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00406	0.0215	CcSEcCtD
Ipratropium bromide—Vision blurred—Metformin—polycystic ovary syndrome	0.00391	0.0207	CcSEcCtD
Ipratropium bromide—Tremor—Metformin—polycystic ovary syndrome	0.00388	0.0205	CcSEcCtD
Ipratropium bromide—Palpitations—Metformin—polycystic ovary syndrome	0.00366	0.0194	CcSEcCtD
Ipratropium bromide—Hypertension—Metformin—polycystic ovary syndrome	0.00358	0.0189	CcSEcCtD
Ipratropium bromide—Myalgia—Metformin—polycystic ovary syndrome	0.00353	0.0187	CcSEcCtD
Ipratropium bromide—Chest pain—Metformin—polycystic ovary syndrome	0.00353	0.0187	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00351	0.0185	CcSEcCtD
Ipratropium bromide—Oedema—Metformin—polycystic ovary syndrome	0.00338	0.0179	CcSEcCtD
Ipratropium bromide—Infection—Metformin—polycystic ovary syndrome	0.00336	0.0178	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00332	0.0175	CcSEcCtD
Ipratropium bromide—Skin disorder—Metformin—polycystic ovary syndrome	0.00329	0.0174	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00327	0.0173	CcSEcCtD
Ipratropium bromide—Hypotension—Metformin—polycystic ovary syndrome	0.00316	0.0167	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00308	0.0163	CcSEcCtD
Ipratropium bromide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00304	0.0161	CcSEcCtD
Ipratropium bromide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00302	0.016	CcSEcCtD
Ipratropium bromide—Somnolence—Metformin—polycystic ovary syndrome	0.00301	0.0159	CcSEcCtD
Ipratropium bromide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00298	0.0158	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00292	0.0154	CcSEcCtD
Ipratropium bromide—Fatigue—Metformin—polycystic ovary syndrome	0.00292	0.0154	CcSEcCtD
Ipratropium bromide—Constipation—Metformin—polycystic ovary syndrome	0.00289	0.0153	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00277	0.0146	CcSEcCtD
Ipratropium bromide—Urticaria—Metformin—polycystic ovary syndrome	0.00269	0.0142	CcSEcCtD
Ipratropium bromide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00267	0.0141	CcSEcCtD
Ipratropium bromide—Asthenia—Metformin—polycystic ovary syndrome	0.00243	0.0128	CcSEcCtD
Ipratropium bromide—Pruritus—Metformin—polycystic ovary syndrome	0.00239	0.0127	CcSEcCtD
Ipratropium bromide—SLC22A4—endometrium—polycystic ovary syndrome	0.00237	0.0617	CbGeAlD
Ipratropium bromide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00232	0.0122	CcSEcCtD
Ipratropium bromide—Dizziness—Metformin—polycystic ovary syndrome	0.00224	0.0118	CcSEcCtD
Ipratropium bromide—Vomiting—Metformin—polycystic ovary syndrome	0.00215	0.0114	CcSEcCtD
Ipratropium bromide—SLC22A4—pituitary gland—polycystic ovary syndrome	0.00215	0.0558	CbGeAlD
Ipratropium bromide—SLC22A4—adipose tissue—polycystic ovary syndrome	0.00214	0.0556	CbGeAlD
Ipratropium bromide—Rash—Metformin—polycystic ovary syndrome	0.00213	0.0113	CcSEcCtD
Ipratropium bromide—Dermatitis—Metformin—polycystic ovary syndrome	0.00213	0.0113	CcSEcCtD
Ipratropium bromide—Headache—Metformin—polycystic ovary syndrome	0.00212	0.0112	CcSEcCtD
Ipratropium bromide—Nausea—Metformin—polycystic ovary syndrome	0.00201	0.0106	CcSEcCtD
Ipratropium bromide—SLC22A4—adrenal gland—polycystic ovary syndrome	0.00192	0.0499	CbGeAlD
Ipratropium bromide—SLC22A4—vagina—polycystic ovary syndrome	0.00178	0.0462	CbGeAlD
Ipratropium bromide—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.00176	0.0457	CbGeAlD
Ipratropium bromide—CHRM3—adipose tissue—polycystic ovary syndrome	0.00169	0.0439	CbGeAlD
Ipratropium bromide—CHRM2—endocrine gland—polycystic ovary syndrome	0.00161	0.0419	CbGeAlD
Ipratropium bromide—SLC22A5—endometrium—polycystic ovary syndrome	0.00157	0.0408	CbGeAlD
Ipratropium bromide—CHRM1—endocrine gland—polycystic ovary syndrome	0.00147	0.0382	CbGeAlD
Ipratropium bromide—SLC22A5—pituitary gland—polycystic ovary syndrome	0.00142	0.0369	CbGeAlD
Ipratropium bromide—SLC22A5—adipose tissue—polycystic ovary syndrome	0.00141	0.0368	CbGeAlD
Ipratropium bromide—CHRM3—female gonad—polycystic ovary syndrome	0.00141	0.0367	CbGeAlD
Ipratropium bromide—CHRM3—endocrine gland—polycystic ovary syndrome	0.00131	0.0341	CbGeAlD
Ipratropium bromide—SLC22A5—adrenal gland—polycystic ovary syndrome	0.00127	0.033	CbGeAlD
Ipratropium bromide—SLC22A5—female gonad—polycystic ovary syndrome	0.00118	0.0308	CbGeAlD
Ipratropium bromide—SLC22A5—vagina—polycystic ovary syndrome	0.00118	0.0306	CbGeAlD
Ipratropium bromide—CYP2D6—female gonad—polycystic ovary syndrome	0.000763	0.0199	CbGeAlD
Ipratropium bromide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000722	0.0188	CbGeAlD
Ipratropium bromide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00071	0.0185	CbGeAlD
Ipratropium bromide—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000216	0.00028	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000215	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000214	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000214	0.000277	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000213	0.000276	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000212	0.000275	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000211	0.000273	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—INSR—polycystic ovary syndrome	0.00021	0.000271	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000208	0.000269	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000207	0.000268	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000205	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000202	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000202	0.000261	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.0002	0.000259	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.0002	0.000259	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000199	0.000258	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000197	0.000255	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000197	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000196	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000196	0.000254	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000196	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000195	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000195	0.000252	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.000195	0.000252	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000194	0.000251	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PGR—polycystic ovary syndrome	0.000194	0.000251	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000194	0.000251	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000194	0.000251	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000193	0.00025	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000193	0.00025	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000192	0.000249	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000192	0.000249	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000192	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.00019	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000188	0.000244	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000188	0.000243	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000187	0.000242	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000186	0.00024	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000185	0.00024	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000182	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000182	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000182	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000181	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00018	0.000234	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00018	0.000234	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.00018	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00018	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.00018	0.000233	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00018	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000179	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000179	0.000232	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000179	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000178	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000178	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000177	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000177	0.000229	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000177	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000176	0.000228	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000176	0.000228	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000174	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000172	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000172	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000171	0.000222	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00017	0.00022	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000169	0.000219	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000169	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000168	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000168	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000167	0.000216	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000167	0.000216	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000167	0.000216	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000167	0.000216	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000167	0.000216	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000166	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000165	0.000214	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000165	0.000214	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000165	0.000213	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000165	0.000213	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000163	0.000211	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000159	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000158	0.000204	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000158	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000157	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000157	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000156	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000155	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000154	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000154	0.000199	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000153	0.000198	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000153	0.000198	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000152	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000152	0.000196	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.00015	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000149	0.000193	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000148	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000147	0.00019	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000146	0.000189	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000142	0.000184	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00014	0.000182	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00014	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000139	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000139	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000138	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000138	0.000179	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000138	0.000178	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000137	0.000178	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000137	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000136	0.000176	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000136	0.000176	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000135	0.000175	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000134	0.000174	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000132	0.000171	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.00013	0.000169	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.00013	0.000168	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00013	0.000168	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000128	0.000166	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000127	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000127	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000127	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000127	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000125	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000125	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000122	0.000158	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000122	0.000158	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000121	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000121	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000121	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000121	0.000156	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00012	0.000155	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.00012	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000118	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000118	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000118	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000117	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000117	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000116	0.000151	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000116	0.00015	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000116	0.00015	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000116	0.00015	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000112	0.000145	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000112	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000112	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000111	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000111	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000111	0.000144	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000111	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000111	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000111	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00011	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00011	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000109	0.000142	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000109	0.000141	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000107	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000107	0.000138	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000107	0.000138	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000106	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000105	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000105	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000105	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000105	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000104	0.000134	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000103	0.000133	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.0001	0.000129	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	9.84e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.84e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	9.79e-05	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.75e-05	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	9.72e-05	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	9.68e-05	0.000125	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	9.63e-05	0.000125	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—POMC—polycystic ovary syndrome	9.33e-05	0.000121	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.29e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—INS—polycystic ovary syndrome	9.27e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.26e-05	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.17e-05	0.000119	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.12e-05	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	9.09e-05	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	9e-05	0.000117	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	8.97e-05	0.000116	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.97e-05	0.000116	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	8.96e-05	0.000116	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.77e-05	0.000113	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.52e-05	0.00011	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	8.52e-05	0.00011	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.49e-05	0.00011	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.28e-05	0.000107	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	7.94e-05	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—polycystic ovary syndrome	7.83e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.81e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.81e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	7.79e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	7.79e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—INS—polycystic ovary syndrome	7.78e-05	0.000101	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	7.71e-05	9.98e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	7.64e-05	9.9e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	7.62e-05	9.86e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.57e-05	9.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	7.55e-05	9.77e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.29e-05	9.44e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.01e-05	9.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	6.95e-05	9e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.92e-05	8.96e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	6.86e-05	8.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.82e-05	8.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	6.8e-05	8.8e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	6.73e-05	8.71e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	6.62e-05	8.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	6.57e-05	8.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	6.55e-05	8.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.54e-05	8.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	6.53e-05	8.45e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	6.51e-05	8.43e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	6.48e-05	8.39e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	6.45e-05	8.34e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.43e-05	8.33e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.32e-05	8.18e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.31e-05	8.17e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.3e-05	8.15e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.29e-05	8.14e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.28e-05	8.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	6.23e-05	8.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	6.23e-05	8.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6e-05	7.76e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.98e-05	7.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.92e-05	7.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.86e-05	7.59e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	5.85e-05	7.58e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.57e-05	7.21e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.42e-05	7.01e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.09e-05	6.59e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.83e-05	6.25e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	4.81e-05	6.23e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	4.77e-05	6.17e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	4.75e-05	6.14e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.68e-05	6.06e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.65e-05	6.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.54e-05	5.88e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.33e-05	5.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.13e-05	5.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.11e-05	5.32e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.1e-05	5.31e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.07e-05	5.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—polycystic ovary syndrome	4.05e-05	5.25e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.83e-05	4.95e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.1e-05	4.02e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.06e-05	3.96e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.04e-05	3.94e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	2.85e-05	3.69e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	2.84e-05	3.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	2.82e-05	3.65e-05	CbGpPWpGaD
